Frontiers in Endocrinology (Sep 2021)
Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations
Abstract
No abstracts available.Keywords
Frontiers in Endocrinology (Sep 2021)